Chantal Schlumberger

Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition

Chantal Schlumberger, D. Schäfer, Caroline Barberi et al. · Behavioural Pharmacology · 2009 · 71 citations

Neuropsychology, Psychopharmacology, Neuropsychiatry +19

Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease

Henrik H. Hansen, Katrine Fabricius, Pernille Barkholt et al. · PLoS ONE · 2016 · 55 citations · Full text

Transgenic Mouse Models, Neurochemical Biomarkers, Synaptic Signaling +20

Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia

Chantal Schlumberger, M. Pietraszek, Andreas Gravius et al. · Pharmacology Biochemistry and Behavior · 2009 · 53 citations

Avoidance Response, Psychiatry, Mglur5 Adx47273 +10

Comparison of the mGlu5 receptor positive allosteric modulator ADX47273 and the mGlu2/3 receptor agonist LY354740 in tests for antipsychotic-like activity

Chantal Schlumberger, M. Pietraszek, Andreas Gravius et al. · European Journal of Pharmacology · 2009 · 48 citations

Antipsychotic-like Activity, Psychiatry, Medicine +8

Ketogenic Diet Suppresses Alcohol Withdrawal Syndrome in Rats

Ditte Dencker, Anna Molander, Morgane Thomsen et al. · Alcoholism Clinical and Experimental Research · 2017 · 39 citations